Mahshid Rafiee, Azar Kariminia, Stephen Wright, Graham Mills, Ian Woolley, Don Smith, David J Templeton, Matthew G Law and Kathy Petoumenos
Reducing viral-load measurements to annual testing in virologically suppressed patients increases the estimated mean time those patients remain on a failing regimen by 6 months. This translates to an increase in the proportion of patients with at least one Thymidine Analogue Mutation from 10% to 32% over one year.
Comparte este artículo